News Directory
Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at media@mtpconnect.org.au.
News
24 May 2022
Introducing Dr Michelle Lam - Senior Program Manager, Clinical Translation and Commercialisation – MedTech (CTCM) Program
We are very pleased to announce the appointment of Dr Michelle Lam as the Senior Program Manager, Clinical Translation and Commercialisation – MedTech (CTCM) Program.
20 May 2022
REDI offers 11 new Industry Training programs for 2022-23 – new brochure out now!
MTPConnect’s Researcher Exchange and Development within Industry (REDI) Initiative has launched 11 new industry training courses/programs with seven new industry partners for 2022-23. The new programs are featured in an updated edition of its courses brochure and online.
17 May 2022
The REDI Fellowship Program Re-opens – Call for Industry Sponsors to Apply
MTPConnect’s popular REDI Fellowship program has re-opened to provide further grants of up to $250,000 to industry to secure a limited number of fellowships in the medical technology, biotechnology and pharmaceutical (MTP) sector.
16 May 2022
In Case You Missed It: Here's What The MTPConnect Team Has Been up to in April
Check out what MTPConnect got up to in April!
16 May 2022
Introducing Dana Bell - Innovation and Translation Intermediary, Adelaide Intermediary Program
We are pleased to announce the appointment of Dana Bell as the Innovation and Translation Intermediary with MTPConnect’s Adelaide Intermediary Program.
16 May 2022
Introducing Lisa Dubé - our new Chief Operating Officer
We are delighted to announce that Lisa Dubé has been appointed to the role of Chief Operating Officer and joins the MTPConnect team today, based in Melbourne.
16 May 2022
REDI News: GSK Australia announces new cohort of Graduate Researchers
GSK Australia is delighted to announce the second year of its Graduate Researcher Program. The 2022 program welcomes a new cohort of six PhD graduates who are working across GSK projects, following the success of the inaugural program last year. The GSK Australia Graduate Researcher Program, supported by the REDI initiative and MTPConnect, looks to bridge the skills gap between academia and the pharmaceutical industry.
12 May 2022
REDI: Announcing New Targeted Training to Boost Medical Product Commercialisation
Continuing the REDI initiative’s commitment to addressing workforce skills gaps, five consortia have been awarded contracts through Round Three of the Contestable program to deliver training and education programs – ARCS Australia Consortium, PRAXIS Australia Consortium, IntelliHQ Consortium, Centre for Biopharmaceutical Excellence Consortium and Wrays Consortium.
12 May 2022
BMTH News: Further boost for Australian Medtech Research Commercialisation
MTPConnect today announced nearly $900,000 in funding for three important medical technology projects in Victoria and Western Australia.
12 May 2022
REDI News: Announcing a New Australian Clinical Entrepreneur Program
MTPConnect is pleased to announce its partner for the REDI supported Australian Clinical Entrepreneur Program (CEP) – the University of Melbourne and University of Western Australia Partnership, which also includes more than 20 other associates, of which five are major hospitals.
12 May 2022
REDI News: Announcing New Industry Fellowships
MTPConnect is pleased to announce that 18 high-skilled Australian researchers, clinicians and professionals from the medical technology, biotechnology and pharmaceutical sector have secured sought-after industry placements under the REDI (Researcher Exchange and Development within Industry) Fellowship program.
09 May 2022
Introducing Pia Vogrin – Engagement and Communications Manager, Adelaide Intermediary Program
MTPConnect is pleased to announce the appointment of Ms Pia Vogrin as Engagement and Communications Manager of MTPConnect’s Adelaide Intermediary Program.
06 May 2022
AAMRNet Calls for New Pilot Fund for Antimicrobials
With antimicrobial resistance (AMR) widely acknowledged as one of the biggest threats to global health, a new position statement from the Australian Antimicrobial Resistance Network (AAMRNet) highlights innovative strategies for bringing new antibiotic treatments to market.
02 May 2022
Please Welcome our New Intern Victoria Mynard
Today we are delighted to announce that Victoria (Tori) Mynard (she/her) is taking up a 2-month internship at MTPConnect working in our BioMedTech Horizons program, based in Melbourne.
29 April 2022
Medical products sector a powerhouse of job creation – new report from MTPConnect
MTPConnect today launched an updated Sector Competitiveness Plan (SCP), tracking the growth of innovation, productivity and competitiveness of Australia’s medical technology, biotechnology and pharmaceutical (MTP) sector.